Health Trials

Comparing Alkalinizing Agents Efficacy on Stone Risk in Patients on a Metabolically Controlled Diet

ConditionKidney Stone
Trial statusNot yet recruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18-90
SponsorUniversity of Texas Southwestern Medical Center

About this trial

The purpose of this study is to compare over the counter and alternative prescription urinary alkalinizing agents to slow release potassium citrate in their ability to modify urinary parameters associated with stone formation.

Eligibility criteria

Qualifiers

Adults aged 18 and older.

with or without a history of stone disease.

Disqualifiers

They are unable to take any of the medications due to health reasons.

Participants are pregnant or nursing.

Participants are unable to adhere to the metabolic diet.

Participants had a prior adverse event from one or more of the medications.

Trial design

Treatments tested in this trial

  • Potassium citrate
  • Sodium bicarbonate
  • Litholyte
  • Crystal Lite
  • Potassium Bicarbonate

Treatment groups

15 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Sponsors and collaborators

University of Texas Southwestern Medical Center

Lead sponsor

Source ClinicalTrials.gov